Clinical trial
Therapeutic Induction of Endogenous Antibiotics for Improved Recovery in Shigellosis
NCT00800930 is registered in ClinicalTrials.gov with International Centre for Diarrhoeal Disease Research, Bangladesh as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Therapeutic Induction of Endogenous Antibiotics for Improved Recovery in Shigellosis
- Lead sponsor
- International Centre for Diarrhoeal Disease Research, Bangladesh
- Phase
- Phase 2
- Overall status
- Completed
- Start date
- January 31, 2005
- Completion date
- January 31, 2009
- Enrollment
- 80 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
shigellosis